Gregory Garland - Amgen Insider

Amgen Inc -- USA Stock  

USD 183.55  0.05  0.0272%

Independent Director

Mr. Gregory C. Garland is an Independent Director of Amgen Inc. Mr. Greg C. Garland is the Chairman and Chief Executive Officer of Phillips 66, an energy manufacturing and logistics company with midstream, chemical, refining and marketing and specialties businesses created through the repositioning of ConocoPhillips, having held this position since April 2012. Mr. Garland chairs the Executive Committee of Phillips 66. Prior to Phillips 66, Mr. Garland served as Senior Vice President, Exploration and Production, Americas of ConocoPhillips from 2010 to April 2012. He was President and Chief Executive Officer of Chevron Phillips Chemical Company from 2008 to 2010 and Senior Vice President, Planning and Specialty Chemicals from 2000 to 2008. Mr. Garland served in various positions at Phillips Petroleum Company from 1980 to 2000. Mr. Garland is a member of the Engineering Advisory Board for Texas AM University. Mr. Garland received an undergraduate degree from Texas AM University.
Age: 58  Director Since 2013      
805-447-1000  http://www.amgen.com

Management Efficiency

The company has return on total asset (ROA) of 8.32 % which means that it generated profit of $8.32 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 7.18 % meaning that it created $7.18 on every $100 dollars invested by stockholders.
The company currently holds 35.34 B in liabilities with Debt to Equity (D/E) ratio of 140.0 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Amgen Inc has Current Ratio of 5.38 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives

DIRECTOR Since

Sally BlountAbbott Laboratories
2011
Peter McDonnellAllergan plc
2015
Shane CookeEndo International plc
2014
Elaine UllianVertex Pharmaceuticals Incorpor
2011
Glenn TiltonAbbott Laboratories
2007
Sangeeta BhatiaVertex Pharmaceuticals Incorpor
2015
Michael HyattEndo International plc
N/A
Nesli BasgozAllergan plc
2014
Nancy HutsonEndo International plc
2009
William OsbornAbbott Laboratories
2013
Ron TaylorAllergan plc
2013
David AltshulerVertex Pharmaceuticals Incorpor
2015
Fred WeissAllergan plc
2013
William SpenglerEndo International plc
2008
Alice SchwartzBio Rad Laboratories Inc
1967
James FarrellAbbott Laboratories
2006
Robert MalchioneBio Rad Laboratories Inc
2014
James BloemAllergan plc
2013
Nancy McKinstryAbbott Laboratories
2011
John StrattonAbbott Laboratories
2017
Adriane BrownAllergan plc
2017

Entity Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California. Amgen operates under Biotechnology classification in USA and traded on NASDAQ exchange. It employs 20800 people.Amgen Inc (AMGN) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 20,800 people. Amgen is listed under Pharmaceutical Products category by Fama And French industry classification.

Did you try this?

Run Fundamentals Matrix Now
   

Fundamentals Matrix

View fundamentals matrix and analyze how accounts are interrelated and interconnected with each other
Hide  View All  NextLaunch Fundamentals Matrix
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Amgen Inc to your portfolio

Top Management

Amgen Inc Leadership Team
Frank Herringer, Director
Francois Carbonnel, Director
Rebecca Henderson, Director, Ph.D
Annette Such, Executive
Sanders Williams, Director
Vance Coffman, Director, Ph.D
Tyler Jacks, Director, Ph.D
Brian McNamee, President
Gregory Garland, Director
Charles Holley, Director
Esteban Santos, President
Jonathan Graham, President
Sean Harper, President, Ph.D
Ellen Kullman, Director
Frank Biondi, Director
Arvind Sood, Executive
David Meline, CFO
Ronald Sugar, Director
Stuart Tross, President
Robert Bradway, Chairman
Wanda Austin, Director
Robert Eckert, Director
Madhavan Balachandran, EVP
Lori Johnston, President
Cynthia Patton, President
Greg Garland, Director
Judith Pelham, Director
David Baltimore, Director, Ph.D
Fred Hassan, Director
David Piacquad, President
Anthony Hooper, EVP

Stock Performance

Amgen Performance Indicators